BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 14716961)

  • 41. Continuous immunotherapy for hymenoptera venom allergy using six month intervals.
    Baenkler HW; Meusser-Storm S; Eger G
    Allergol Immunopathol (Madr); 2005; 33(1):7-14. PubMed ID: 15777517
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients.
    Fricker M; Helbling A; Schwartz L; Müller U
    J Allergy Clin Immunol; 1997 Jul; 100(1):11-5. PubMed ID: 9257781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diagnosis of hymenoptera venom allergy].
    Peláez Hernández A
    Allergol Immunopathol (Madr); 1994; 22(4):161-5. PubMed ID: 7976969
    [No Abstract]   [Full Text] [Related]  

  • 44. Basophil activation test for the diagnosis of hymenoptera venom allergy in childhood: a pilot study.
    Ott H; Tenbrock K; Baron J; Merk H; Lehmann S
    Klin Padiatr; 2011 Jan; 223(1):27-32. PubMed ID: 21271515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of immunoglobulins to venoms during specific immunotherapy.
    Palma-Carlos ML; Santos MC; Pedro E; Branco-Ferreira M; Spínola A; Palma-Carlos AG
    Allerg Immunol (Paris); 1999 Mar; 31(3):71-2. PubMed ID: 10226679
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Serological study of Hymenoptera allergy. 1. Evaluation of the allergenic properties common to wild Hymenoptera and honeybees].
    Mitsuhashi M; Natsukawa S; Agatsuma Y
    Arerugi; 1982 Oct; 31(10):1056-62. PubMed ID: 7168648
    [No Abstract]   [Full Text] [Related]  

  • 47. [Change in venom-specific IgE levels during 2-year follow-up in five cases with a history of Hymenoptera sting].
    Ono T; Yoshida M; Nakazono N
    Arerugi; 1997 Nov; 46(11):1163-9. PubMed ID: 9436334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Allergens in hymenoptera venom. IX. Species specificity to Polistes (paper wasp) venoms.
    Hoffman DR; McDonald CA
    Ann Allergy; 1982 Feb; 48(2):82-6. PubMed ID: 7065471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Allergy to Hymenoptera].
    Beretta E
    Rev Med Suisse Romande; 1986 Sep; 106(9):801-8. PubMed ID: 2877485
    [No Abstract]   [Full Text] [Related]  

  • 50. Ultrarush immunotherapy in patients with Hymenoptera venom allergy.
    Ruëff F; Przybilla B
    J Allergy Clin Immunol; 2001 May; 107(5):928-9. PubMed ID: 11344369
    [No Abstract]   [Full Text] [Related]  

  • 51. Rush Hymenoptera venom immunotherapy: successful treatment in a patient with systemic mast cell disease.
    Engler RJ; Davis WS
    J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 1):556-9. PubMed ID: 8083461
    [No Abstract]   [Full Text] [Related]  

  • 52. Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab.
    Galera C; Soohun N; Zankar N; Caimmi S; Gallen C; Demoly P
    J Investig Allergol Clin Immunol; 2009; 19(3):225-9. PubMed ID: 19610266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Venom extracts available to treat patients at risk from insect stings.
    Gunby P
    JAMA; 1979 May; 241(21):2243-6. PubMed ID: 439282
    [No Abstract]   [Full Text] [Related]  

  • 54. Cellular in vitro assays in the diagnosis of Hymenoptera venom allergy.
    Scherer K; Weber JM; Jermann TM; Krautheim A; Tas E; Ueberschlag EV; Cammarata M; Bircher AJ
    Int Arch Allergy Immunol; 2008; 146(2):122-32. PubMed ID: 18204278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and Hymenoptera allergy.
    Bonadonna P; Zanotti R; Caruso B; Castellani L; Perbellini O; Colarossi S; Chilosi M; Dama A; Schiappoli M; Pizzolo G; Senna G; Passalacqua G
    J Allergy Clin Immunol; 2008 Jan; 121(1):256-7. PubMed ID: 18206512
    [No Abstract]   [Full Text] [Related]  

  • 56. Prevalence of allergic reactions to Hymenoptera stings in northern Italy.
    Incorvaia C; Senna G; Mauro M; Bonadonna P; Marconi I; Asero R; Nitti F
    Eur Ann Allergy Clin Immunol; 2004 Dec; 36(10):372-4. PubMed ID: 15662965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Allergy to Hymenoptera venom in children. Diagnosis and therapy].
    Pastorello EA; Incorvaia C; Sarassi A; Qualizza R; Guidoboni A; Farioli L
    Minerva Pediatr; 1989 Aug; 41(8):419-23. PubMed ID: 2601661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment of allergies to Hymenoptera venom].
    Charpin J; Vervloet D; Birnbaum J
    Bull Acad Natl Med; 1982 Apr; 166(4):539-44. PubMed ID: 6751497
    [No Abstract]   [Full Text] [Related]  

  • 59. Monitoring of specific immunotherapy with 3M Fluoro-FAST in insect sting sensitive patients.
    Szymański W; Kazberuk M; Chyrek-Borowska S
    Pneumonol Alergol Pol; 1992; 60 Suppl 1():63-6. PubMed ID: 1292850
    [No Abstract]   [Full Text] [Related]  

  • 60. Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients.
    Sturm G; Kränke B; Rudolph C; Aberer W
    J Allergy Clin Immunol; 2002 Dec; 110(6):928-33. PubMed ID: 12464961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.